68 related articles for article (PubMed ID: 34742871)
21. The down-regulation of melanogenesis via MITF and FOXO1 signaling pathways in SIRT1 knockout cells using CRISPR/Cas9 system.
Jeon S; Kim MM
J Biotechnol; 2021 Dec; 342():114-127. PubMed ID: 34757047
[TBL] [Abstract][Full Text] [Related]
22. FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell-Mediated Bladder Cancer Immune Surveillance.
Jing W; Wang G; Cui Z; Xiong G; Jiang X; Li Y; Li W; Han B; Chen S; Shi B
Cancer Res; 2022 Jan; 82(1):114-129. PubMed ID: 34753771
[TBL] [Abstract][Full Text] [Related]
23. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.
Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M
J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750
[TBL] [Abstract][Full Text] [Related]
24. The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013.
Ferrer S; Muratore ME; Buijnsters P
Expert Opin Ther Pat; 2022 May; 32(5):523-559. PubMed ID: 34743664
[TBL] [Abstract][Full Text] [Related]
25. In the Rat Hippocampus, Pilocarpine-Induced Status Epilepticus Is Associated with Reactive Glia and Concomitant Increased Expression of CD31, PDGFRβ, and Collagen IV in Endothelial Cells and Pericytes of the Blood-Brain Barrier.
Kyriatzis G; Bernard A; Bôle A; Khrestchatisky M; Ferhat L
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338969
[TBL] [Abstract][Full Text] [Related]
26. CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression.
Gu Y; Wu S; Fan J; Meng Z; Gao G; Liu T; Wang Q; Xia H; Wang X; Wu K
Cell Death Dis; 2024 Jan; 15(1):79. PubMed ID: 38246916
[TBL] [Abstract][Full Text] [Related]
27. Deubiquitinating enzyme JOSD2 affects susceptibility of non-small cell lung carcinoma cells to anti-cancer drugs through DNA damage repair.
Ge F; Liu X; Zhang H; Yuan T; Zhu H; Yang B; He Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):533-543. PubMed ID: 37899394
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency.
Bekas N; Samiotaki M; Papathanasiou M; Mokos P; Pseftogas A; Xanthopoulos K; Thanos D; Mosialos G; Dafou D
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894364
[No Abstract] [Full Text] [Related]
29. USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target.
Li S; Song Y; Wang K; Liu G; Dong X; Yang F; Chen G; Cao C; Zhang H; Wang M; Li Y; Zeng T; Liu C; Li B
Cell Death Discov; 2023 Sep; 9(1):338. PubMed ID: 37679322
[TBL] [Abstract][Full Text] [Related]
30. USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression.
Tyagi A; Karapurkar JK; Colaco JC; Sarodaya N; Antao AM; Kaushal K; Haq S; Chandrasekaran AP; Das S; Singh V; Hong SH; Suresh B; Kim KS; Ramakrishna S
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37572221
[TBL] [Abstract][Full Text] [Related]
31. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression.
Compagnoni C; Capelli R; Zelli V; Corrente A; Vecchiotti D; Flati I; Di Vito Nolfi M; Angelucci A; Alesse E; Zazzeroni F; Tessitore A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298191
[TBL] [Abstract][Full Text] [Related]
32. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation.
Huang Z; Tan Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176077
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas9-based genome-wide screening of the deubiquitinase subfamily identifies USP3 as a protein stabilizer of REST blocking neuronal differentiation and promotes neuroblastoma tumorigenesis.
Karapurkar JK; Kim MS; Colaco JC; Suresh B; Sarodaya N; Kim DH; Park CH; Hong SH; Kim KS; Ramakrishna S
J Exp Clin Cancer Res; 2023 May; 42(1):121. PubMed ID: 37170124
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of a Novel Noxo1 Mutant Increases Ros Production and Noxo1 Relocalisation.
Benssouina FZ; Parat F; Villard C; Leloup L; Garrouste F; Sabatier JM; Ferhat L; Kovacic H
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902094
[TBL] [Abstract][Full Text] [Related]
35. Development of a prognostic model for children with neuroblastoma based on necroptosis-related genes.
Jing Chu
Front Genet; 2022; 13():947000. PubMed ID: 35991559
[No Abstract] [Full Text] [Related]
36. CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.
Tyagi A; Kaushal K; Chandrasekaran AP; Sarodaya N; Das S; Park CH; Hong SH; Kim KS; Ramakrishna S
Theranostics; 2022; 12(13):5949-5970. PubMed ID: 35966591
[No Abstract] [Full Text] [Related]
37. Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.
Erol A
Cancer Manag Res; 2022; 14():2339-2356. PubMed ID: 35958947
[TBL] [Abstract][Full Text] [Related]
38. Deubiquitinase USP19 enhances phenylalanine hydroxylase protein stability and its enzymatic activity.
Sarodaya N; Tyagi A; Kim HJ; Colaco JC; Kang JS; Kim WJ; Kim KS; Ramakrishna S
Cell Biol Toxicol; 2023 Oct; 39(5):2295-2310. PubMed ID: 35449354
[TBL] [Abstract][Full Text] [Related]
39. CYLD destabilizes NoxO1 protein by promoting ubiquitination and regulates prostate cancer progression.
Haq S; Sarodaya N; Karapurkar JK; Suresh B; Jo JK; Singh V; Bae YS; Kim KS; Ramakrishna S
Cancer Lett; 2022 Jan; 525():146-157. PubMed ID: 34742871
[TBL] [Abstract][Full Text] [Related]
40. NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells.
Joo JH; Oh H; Kim M; An EJ; Kim RK; Lee SY; Kang DH; Kang SW; Keun Park C; Kim H; Lee SJ; Lee D; Seol JH; Bae YS
Cancer Res; 2016 Feb; 76(4):855-65. PubMed ID: 26781991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
